SEC Follow Up Exhibits Part C SEC_OEA_FCIC_001760-2501

2013 at a redemption price per share equal to the greater of (i) 125% of the liquidation preference and (ii) the average of the closing
prices of the common stock for the ten trading days ending on the sixth trading day prior to the date of redemption multiplied by the
number of shares of common stock into which one share of Series G Preferred Stock would be convertible on such date if such shares
of Series G Preferred Stock were converted on that date following receipt of the stockholder approvals described above, together with
(x) an amount equal to any dividends that have been declared but not paid prior to the redemption date and (y) an amount equal to any
dividends for periods after such issuance for which dividends were not declared and paid prior to the redemption date.
Prior to resales by use of this prospectus supplement, there has been no public market for the Series G Preferred Stock.
The selling stockholders may sell the securities on the open market at market prices in ordinary broker transactions or in
negotiated transactions, and they may pay broker commissions in connection with such transactions. The selling stockholders and any
broker dealer executing sell orders on behalf of or purchasing from the selling stockholders may be deemed to be an “underwriter”
within the meaning of the Securities Act of 1933 (the “Securities Act”). Commissions received by any such broker dealer may be
deemed to be underwriting commissions or discounts under the Securities Act.
The securities are not savings accounts, deposits or other obligations of any bank and are not insured or guaranteed by the
Federal Deposit Insurance Corporation or any other government agency.
Investing in the securities involves risks. See “Risk Factors” on page S-6 of this prospectus
supplement to read about factors you should consider before buying securities.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a
criminal offense.
May 16, 2008.